Intracellular Delivery of CRISPR/Cas9 via Living Bacteria to Block Arginine Metabolic Reprogramming and Enhance Tumor Chemotherapy Sensitivity
Year: 2025
Type: article
Source: Advanced Functional Materials
Institutions: Tongji University, Shanghai Skin Disease Hospital
Language: English
Subfield: Biotechnology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4413456830
